Home › Funds › WorthPointe, LLC › IBD

WorthPointe, LLC position in IBD

NORTHERN LTS FD TR IV

WorthPointe, LLC reported holding 154,171 shares of IBD (NORTHERN LTS FD TR IV) in its Q2 2026 13F filing — a position valued at US$3.7M, representing 0.92% of its reported portfolio and ranking #23 among its reported holdings. WorthPointe, LLC has disclosed IBD holdings in 5 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)154.17K sh
Reported value held$3.66M
Portfolio Weight0.92%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How WorthPointe, LLC's IBD position evolved

WorthPointe, LLC first disclosed a stake in IBD in Q3 2023 at 41,095 shares (US$930K). The position peaked in Q4 2025 at 312,296 shares, worth US$7.6M. Across 5 filings, WorthPointe, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 154,171 shares valued at US$3.7M — a reduction of -52,796 shares quarter over quarter.. Notable position changes include a 168% increase in Q4 2023 (shares were roughly flat over the following quarter), a 34% trim in Q1 2026 (shares were roughly flat over the following quarter), a 26% trim in Q2 2026 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 41.09K $930.39K New
Q4 2023 110.14K $2.60M Add
Q4 2025 312.30K $7.56M New
Q1 2026 206.97K $4.94M Reduce
Q2 2026 154.17K $3.66M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBD and 13F data

IBD (NORTHERN LTS FD TR IV) is a company whose sector is not yet classified in our data. 30 other funds we track also report a position in IBD — the largest reported positions include Inspire Advisors, LLC (US$97.5M), Faithward Advisors, LLC (US$40.8M), CREATIVE FINANCIAL DESIGNS INC /ADV (US$23.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBD

All IBD fund holders →

FAQ

How long has WorthPointe, LLC held IBD?

WorthPointe, LLC has disclosed IBD holdings in 5 of the last 12 reported quarters, going back to Q3 2023.

What is WorthPointe, LLC's current position in IBD?

As of Q2 2026, WorthPointe, LLC holds 154.17K shares of IBD (NORTHERN LTS FD TR IV), valued at $3.66M, representing 0.92% of its reported portfolio and ranking #23.

Has WorthPointe, LLC been buying or selling IBD?

In the latest 13F filing (Q2 2026), WorthPointe, LLC reduced its position in IBD. The position peaked in Q4 2025 at 312.30K shares.

Which other funds hold IBD?

Other major institutional holders of IBD include Inspire Advisors, LLC, Faithward Advisors, LLC, CREATIVE FINANCIAL DESIGNS INC /ADV, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.